April 12, 2018 / 5:34 AM / 3 months ago

BRIEF-Wilson with Promising Preliminary Long Term Data

April 12 (Reuters) - Wilson Therapeutics AB:

* TERM DATA FOR WTX101 IN WILSON DISEASE PRESENTED AT EASL ANNUAL MEETING

* SAYS ONCE-DAILY TREATMENT WITH WTX101 SIGNIFICANTLY REDUCES FREE COPPER LEVELS IN PATIENTS WITH WILSON DISEASE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below